PLEKHA5 regulates the survival and peritoneal dissemination of diffuse-type gastric carcinoma cells with Met gene amplification

PLEKHA5 regulates the survival and peritoneal dissemination of diffuse-type gastric carcinoma cells with Met gene amplification

Abstract Met gene amplification has been found in a subset of malignant carcinomas, including diffuse-type gastric carcinoma (DGC), which has a poor prognosis owing to rapid infiltrative invasion and frequent peritoneal dissemination. Met is considered a promising therapeutic target for DGC. However...

Full description

Bibliographic Details
Main Authors:	Yuko Nagamura, Makoto Miyazaki, Yoshiko Nagano, Masako Yuki, Kiyoko Fukami, Kazuyoshi Yanagihara, Kazuki Sasaki, Ryuichi Sakai, Hideki Yamaguchi
Format:	Article
Language:	English
Published:	Nature Publishing Group 2021-03-01
Series:	Oncogenesis
Online Access:	https://doi.org/10.1038/s41389-021-00314-1

Similar Items

SHP2 as a Potential Therapeutic Target in Diffuse-Type Gastric Carcinoma Addicted to Receptor Tyrosine Kinase Signaling
by: Yuko Nagamura, et al.
Published: (2021-08-01)

WW, PH and C-Terminal Domains Cooperate to Direct the Subcellular Localizations of PLEKHA5, PLEKHA6 and PLEKHA7
by: Sophie Sluysmans, et al.
Published: (2021-09-01)

Stromal fibroblasts mediate extracellular matrix remodeling and invasion of scirrhous gastric carcinoma cells.
by: Hideki Yamaguchi, et al.
Published: (2014-01-01)

PLEKHA4/kramer Attenuates Dishevelled Ubiquitination to Modulate Wnt and Planar Cell Polarity Signaling
by: Adnan Shami Shah, et al.
Published: (2019-05-01)

<i>PLEKHA8P1</i> Promotes Tumor Progression and Indicates Poor Prognosis of Liver Cancer
by: Jiyeon Lee, et al.
Published: (2021-07-01)

The Expression of the Zonula Adhaerens Protein PLEKHA7 Is Strongly Decreased in High Grade Ductal and Lobular Breast Carcinomas.
by: Jean-Christophe Tille, et al.
Published: (2015-01-01)

Characterization of BRCA1-deficient premalignant tissues and cancers identifies Plekha5 as a tumor metastasis suppressor
by: Jianlin Liu, et al.
Published: (2020-09-01)

PLEKHA7 is an adherens junction protein with a tissue distribution and subcellular localization distinct from ZO-1 and E-cadherin.
by: Pamela Pulimeno, et al.
Published: (2010-08-01)

Simultaneous E-cadherin and PLEKHA7 expression negatively affects E-cadherin/EGFR mediated ovarian cancer cell growth
by: Katia Rea, et al.
Published: (2018-07-01)

Direct Interaction between Carcinoma Cells and Cancer Associated Fibroblasts for the Regulation of Cancer Invasion
by: Hideki Yamaguchi, et al.
Published: (2015-10-01)

Investigating the role of pleckstrin homology domain containing, family A member 1 (PLEKHA1) in Age-related macular degeneration(AMD)
by: Chi-Tang Wang, et al.
Published: (2015)

Targeting MET Amplification as a New Oncogenic Driver
by: Hisato Kawakami, et al.
Published: (2014-07-01)

PLEKHA7, an Apical Adherens Junction Protein, Suppresses Inflammatory Breast Cancer in the Context of High E-Cadherin and p120-Catenin Expression
by: Lindy J. Pence, et al.
Published: (2021-01-01)

MET overexpression and gene amplification in NSCLC: a clinical perspective
by: Landi L, et al.
Published: (2013-06-01)

Disposition Kinetics of Taxanes in Peritoneal Dissemination
by: Ken'ichi Miyamoto, et al.
Published: (2012-01-01)

MET Gene Amplification and MET Receptor Activation Are Not Sufficient to Predict Efficacy of Combined MET and EGFR Inhibitors in EGFR TKI-Resistant NSCLC Cells.
by: Dario Presutti, et al.
Published: (2015-01-01)

Anti-interferon-gamma autoantibody related disseminated nontuberculous mycobacteriosis with pathological features of immunoglobulin G4-related disease
by: Norihiro Nagamura, et al.
Published: (2021-05-01)

Met in Urological Cancers
by: Yasuyoshi Miyata, et al.
Published: (2014-12-01)

Comparison of in situ and extraction-based methods for the detection of MET amplifications in solid tumors
by: Carina Heydt, et al.
Published: (2019-01-01)

Precision medicine approaches to lung adenocarcinoma with concomitant MET and HER2 amplification
by: Doo-Yi Oh, et al.
Published: (2017-08-01)

Prognosis and Concurrent Genomic Alterations in Patients With Advanced NSCLC Harboring MET Amplification or MET Exon 14 Skipping Mutation Treated With MET Inhibitor: A Retrospective Study
by: Li Liu, et al.
Published: (2021-06-01)

Targeted transcript quantification in single disseminated cancer cells after whole transcriptome amplification.
by: Franziska C Durst, et al.
Published: (2019-01-01)

Absolute quantitation of Met using mass spectrometry for clinical application: assay precision, stability, and correlation with MET gene amplification in FFPE tumor tissue.
by: Daniel V T Catenacci, et al.
Published: (2014-01-01)

Disseminated Peritoneal Leiomyomatosis
by: Mozhdeh Momtahan, et al.
Published: (2011-03-01)

MET exon 14 skipping mutations and gene amplification in a Taiwanese lung cancer population.
by: Jrhau Lung, et al.
Published: (2019-01-01)

Catechol-O-methyltransferase Val158Met polymorphism is associated with somatosensory amplification and nocebo responses.
by: Laura Wendt, et al.
Published: (2014-01-01)

Prognostic significance of MET amplification and expression in gastric cancer: a systematic review with meta-analysis.
by: Zhi Peng, et al.
Published: (2014-01-01)

MET-overexpressing myxofibrosarcoma frequently exhibit polysomy of chromosome 7 but not MET amplification, especially in high-grade cases: clinical and pathological review of 30 myxofibrosarcoma cases
by: Shirong Ma, et al.
Published: (2018-08-01)

Gefitinib inhibits invasive phenotype and epithelial-mesenchymal transition in drug-resistant NSCLC cells with MET amplification.
by: Silvia La Monica, et al.
Published: (2013-01-01)

Successful crizotinib monotherapy in EGFR-mutant lung adenocarcinoma with acquired MET amplification after erlotinib therapy
by: Katsuhiro Yoshimura, MD, et al.
Published: (2017-01-01)

Micropatterned co-culture of hepatocyte spheroids layered on non-parenchymal cells to understand heterotypic cellular interactions
by: Hidenori Otsuka, Kohei Sasaki, Saya Okimura, Masako Nagamura and Yuichi Nakasone
Published: (2013-01-01)

Microcapsule-Based Signal Amplification Method for Biomolecules
by: Masaki Yamaguchi
Published: (2019-06-01)

Resonant primordial gravitational waves amplification
by: Chunshan Lin, et al.
Published: (2016-01-01)

Intraperitoneal cancer-immune microenvironment promotes peritoneal dissemination of gastric cancer
by: Shuichi Sakamoto, et al.
Published: (2019-12-01)

MET exon 14 skipping mutation, amplification and overexpression in pulmonary sarcomatoid carcinoma: A multi-center study
by: Xue-wen Liu, et al.
Published: (2020-12-01)

Whole abdominopelvic intensity-modulated radiation therapy for peritoneal disseminated rhabdomyosarcoma with three-year follow-up: a case report
by: Mariko Kawamura, et al.
Published: (2019-07-01)

Risk of peritoneal dissemination in stomach cancer
by: Sitarz Robert, et al.
Published: (2017-12-01)

Detection of high serum levels of β-D-Glucan in disseminated nocardial infection: a case report
by: Toyomitsu Sawai, et al.
Published: (2017-04-01)

Response to gefitinib/crizotinib combination in a pulmonary sarcomatoid carcinoma patient harboring concurrent EGFR mutation and MET amplification
by: Xiaomeng Wang, et al.
Published: (2021-07-01)

Transformation from adenocarcinoma to squamous cell lung carcinoma with MET amplification after lorlatinib resistance: A case report
by: Shoko Ueda, et al.
Published: (2021-03-01)